Read More Pharma Industry News Avacta completes Coris sale in final diagnostics exit: Is its precision oncology pivot ready for prime time? Avacta completes sale of Coris Bioconcept to focus solely on oncology. Find out what this pivot means for its stock, strategy, and pre|CISION® pipeline. byPallavi MadhirajuSeptember 2, 2025